Figure 3.
Canofin and Lysyl oxidase propeptide (LOX-PP) similarly inhibited AKT phosphorylation and promoted PPARγ expression. (A) LOX-PP and canofin, a peptide competitive inhibitor of FGF-2 receptor, inhibited AKT signaling; (B) LOX-PP and canofin abolished the inhibitory effects of FGF-2 on PPARγ expression. (Means ± SEM; **P < 0.01)